Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
3.210
-0.270 (-7.76%)
At close: Dec 5, 2025, 4:00 PM EST
3.220
+0.010 (0.31%)
After-hours: Dec 5, 2025, 7:55 PM EST
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $6.69 million as of December 5, 2025. Its market cap has decreased by -76.69% in one year.
Market Cap
6.69M
Enterprise Value
1.06M
1-Year Change
-76.69%
Ranking
Category
Stock Price
$3.21
Market Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $6.69M, a decrease of -88.31%. That is a compound annual growth rate of -38.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 7.26M | -47.22% |
| Dec 31, 2024 | 13.75M | -73.92% |
| Dec 29, 2023 | 52.73M | 14.29% |
| Dec 30, 2022 | 46.14M | 4.51% |
| Dec 31, 2021 | 44.15M | -22.88% |
| Jun 25, 2021 | 57.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.68B |
| Johnson & Johnson | 494.92B |
| AbbVie | 396.55B |
| UnitedHealth Group | 293.98B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 250.76B |
| Abbott Laboratories | 219.65B |